The patented SKAN NANOX Catalysts enable higher efficiency breakdown of hydrogen peroxide at lower temperatures for shorter decontamination cycles.
The patented SKAN NANOX Catalysts were developed in cooperation with a Swiss university and engineered to enable higher efficiency breakdown of hydrogen peroxide at lower temperatures. The catalyst reduces the overall time and energy required for hydrogen peroxide-based decontamination and aeration, while positively impacting the effect on the environment.
The catalyst can be used in aseptic processing isolators, such as SKAN’s modular, small-scale Pharmaceutical Safety Isolator (PSI-L) with SARA material airlocks for conventional aseptic applications. The short decontamination cycle and the return air filter make it a universal, aseptic workspace for the production of aseptic and/or highly active pharmaceutical products.
Source: SKAN
WMFTS’ BioPure to Showcase Single-Use Bioclamp with Refined Manufacturing at INTERPHEX 2025
April 1st 2025With advanced manufacturing, BioPure’s BioClamp connector is manufactured to be 13% lighter than the previous model, resulting in a 26% reduction in carbon dioxide emissions across the full lifecycle of the product.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.